Novax DMA
Develops and manufactures patient-specific 3D printed titanium and PEEK implants for complex trauma, orthopedics, spine, and cranio-maxillofacial surgery, reducing surgical time and improving patient outcomes.
- CEO / Founder
- Fiz Daniel
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $0
- Latest Round
- None
- Key Investors
- Not publicly disclosed
Technology & Products
Key Products
Patient-specific 3D printed titanium and PEEK implants for trauma, orthopedics, spine, and cranio-maxillofacial surgery.
Technological Advantage
Proprietary expertise in designing and manufacturing patient-specific implants using metal LPBF (laser powder bed fusion) technology, with over 10 years of additive manufacturing experience and IRAM certification for medical devices.
Differentiation
Value Proposition
Provides customized, patient-specific implants that offer perfect anatomical fit, reduce surgical time by up to 30%, and improve patient recovery outcomes compared to standard off-the-shelf implants.
How They Differentiate
Focuses on patient-specific, customized implants using 3D printing (vs. standard off-the-shelf implants from large competitors), with expertise in complex trauma cases and a presence in over 15 countries, particularly strong in South America.
Market & Competition
Target Customers
Surgeons and hospitals specializing in orthopedics, traumatology, spine, and cranio-maxillofacial surgery
Industry Verticals
Medical Devices; Healthcare; Orthopedics; Traumatology; Spine Surgery; Cranio-Maxillofacial Surgery
Competitors
ExacTech, Biofab
Growth & Milestones
Growth Metrics
Annual revenue of $5.5 million in 2025; operates in over 15 countries worldwide.
Major Milestones
Founded in 1995; Started using additive manufacturing technologies over 10 years ago; Developed 3D printed cranial implant using Trabecular Titanium system (2015); Partnered with Protolabs for specialized part production
Notable Customers
Not publicly disclosed